Orkambi Indication Expanded to Include More Children With Cystic Fibrosis
The safety profile of Orkambi was found to be similar in patients aged 1 to less than 2 years compared with those 2 years of age and older.
Restrictive Lung Disease
Risk Stratification in Cystic Fibrosis Patients Listed for Lung Transplantation
A newly developed cystic fibrosis frailty index calculates the risk for poor outcomes both in patients post lung transplant and among those awaiting transplant.
Early Cystic Fibrosis Airway Disease Markers and PD-1
Do links exist between macrophage programmed cell death protein-1 (PD-1) and markers of airway disease in very young children with cystic fibrosis?
Predicting Pediatric CF Events with Patient-Reported Outcomes and Lung Measures
Can acute respiratory events in children with cystic fibrosis be predicted using PRO tools that measure patient- and parent-reported respiratory symptoms?
High-Resolution CT Scoring Promising for RA-Associated Interstitial Lung Disease
Researchers reviewed 2 studies that evaluated high-resolution computed tomography images (HCRT) and their ability to predict important clinical outcomes for rheumatoid arthritis-associated interstitial lung disease (RA-ILD).
Azithromycin and Structural Lung Disease in Newborns With Cystic Fibrosis
Will azithromycin, given 3 times weekly to infants with cystic fibrosis from diagnosis until age 36 months, reduce damage from structural lung disease?
Prognosis After Acute Exacerbation in Rheumatoid Arthritis-ILD vs IPF
How frequent are acute exacerbations in rheumatoid arthritis-related ILD and how does the prognosis for these compare with AEs in idiopathic pulmonary fibrosis?
Efficacy/Safety of Idiopathic Pulmonary Fibrosis Treatment With BI 1015550
A phase 2 trial explored the efficacy and safety of BI 1015550 — an oral preferential inhibitor of the PDE4B subtype — in patients with IPF.
Risk Score Developed for RA-Linked Interstitial Lung Disease
A score has been developed to stratify the risk for subclinical rheumatoid arthritis-associated interstitial lung disease (RA-ILD).
Pulmonary Ultrasonography Detects Interstitial Lung Disease in Rheumatoid Arthritis
Researchers investigated the potential role in ultrasonography in the detection of interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA).
- Loading...
Loading...
Next post in Restrictive Lung Disease
Loading... 
Loading...